Literature DB >> 9174209

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

K A Rodvold1, M H Gotfried, L H Danziger, R J Servi.   

Abstract

The steady-state concentrations of clarithromycin and azithromycin in plasma were compared with concomitant concentrations in epithelial lining fluid (ELF) and alveolar macrophages (AM) obtained in intrapulmonary samples during bronchoscopy and bronchoalveolar lavage from 40 healthy, nonsmoking adult volunteers. Mean plasma clarithromycin, 14-(R)-hydroxyclarithromycin, and azithromycin concentrations were similar to those previously reported. Clarithromycin was extensively concentrated in ELF (range of mean +/- standard deviation concentrations, 34.4 +/- 29.3 microg/ml at 4 h to 4.6 +/- 3.7 microg/ml at 24 h) and AM (480 +/- 533 microg/ml at 4 h to 99 +/- 50 microg/ml at 24 h). The concentrations of azithromycin in ELF were 1.01 +/- 0.45 microg/ml at 4 h to 1.22 +/- 0.59 microg/ml at 24 h, and those in AM were 42.7 +/- 28.7 microg/ml at 4 h to 41.7 +/- 12.1 microg/ml at 24 h. The concentrations of 14-(R)-hydroxyclarithromycin in the AM ranged from 89.3 +/- 52.8 microg/ml at 4 h to 31.3 +/- 17.7 microg/ml at 24 h. During the period of 24 h after drug administration, azithromycin and clarithromycin achieved mean concentrations in ELF and AM higher than the concomitant concentrations in plasma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174209      PMCID: PMC163925          DOI: 10.1128/AAC.41.6.1399

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

3.  High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues.

Authors:  R M Shepard; G S Duthu; R A Ferraina; M A Mullins
Journal:  J Chromatogr       Date:  1991-04-19

4.  Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection.

Authors:  S Y Chu; L T Sennello; R C Sonders
Journal:  J Chromatogr       Date:  1991-11-15

5.  High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.

Authors:  D L Morris; A De Souza; J A Jones; W E Morgan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

6.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.

Authors:  M S Niederman; J B Bass; G D Campbell; A M Fein; R F Grossman; L A Mandell; T J Marrie; G A Sarosi; A Torres; V L Yu
Journal:  Am Rev Respir Dis       Date:  1993-11

7.  Penetration of clarithromycin into lung tissues from patients undergoing lung resection.

Authors:  D N Fish; M H Gotfried; L H Danziger; K A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.

Authors:  F Bradbury
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

9.  The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.

Authors:  F Fraschini; F Scaglione; G Pintucci; G Maccarinelli; S Dugnani; G Demartini
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

Review 10.  Clarithromycin and azithromycin: new macrolide antibiotics.

Authors:  S C Piscitelli; L H Danziger; K A Rodvold
Journal:  Clin Pharm       Date:  1992-02
View more
  43 in total

1.  Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae.

Authors:  K L Bergman; K M Olsen; T E Peddicord; P D Fey; M E Rupp
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review).

Authors:  Markus Zeitlinger; Markus Müller; Christian Joukhadar
Journal:  AAPS J       Date:  2005-10-22       Impact factor: 4.009

3.  Clarithromycin in the Treatment of Legionella pneumophila Pneumonia Associated with Multiorgan Failure in a Previously Healthy Patient.

Authors:  L Gallelli; V Gioffrè; G Vero; A Gallelli; F Roccia; S Naty; G Pelaia; A Capano; A Loiacono; G De Sarro; R Maselli
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis.

Authors:  Friederike Traunmüller; Markus Zeitlinger; Petra Zeleny; Markus Müller; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

Review 5.  Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

6.  Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation.

Authors:  Christopher M Rubino; Lei Ma; Sujata M Bhavnani; Joan Korth-Bradley; John Speth; Evelyn Ellis-Grosse; Keith R Rodvold; Paul G Ambrose; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

7.  Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.

Authors:  Brian T Tsuji; James Fisher; Raheal Boadi-Yeboah; Patricia N Holden; Sanjay Sethi; Melinda M Pettigrew; Timothy F Murphy
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 8.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 9.  Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Authors:  Markus Zeitlinger; Claudia Christina Wagner; Birgit Heinisch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).

Authors:  C Muller-Serieys; P Soler; C Cantalloube; F Lemaitre; H P Gia; F Brunner; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.